These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7518305)

  • 1. Cardiovascular and behavioural effects of centrally administered neuropeptide K in the rat: receptor characterization.
    Prat A; Picard P; Couture R
    Br J Pharmacol; 1994 May; 112(1):250-6. PubMed ID: 7518305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P; Regoli D; Couture R
    Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracerebroventricular responses to neuropeptide gamma in the conscious rat: characterization of its receptor with selective antagonists.
    Picard P; Couture R
    Br J Pharmacol; 1996 Jan; 117(2):241-9. PubMed ID: 8789375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular responses to intrathecal neuropeptide gamma in conscious rats: receptor characterization and mechanism of action.
    Poulat P; de Champlain J; Couture R
    Br J Pharmacol; 1996 Jan; 117(2):250-7. PubMed ID: 8789376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
    Cellier E; Barbot L; Regoli D; Couture R
    Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress.
    Culman J; Klee S; Ohlendorf C; Unger T
    J Pharmacol Exp Ther; 1997 Jan; 280(1):238-46. PubMed ID: 8996202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.
    Culman J; Wiegand B; Spitznagel H; Klee S; Unger T
    Br J Pharmacol; 1995 Mar; 114(6):1310-6. PubMed ID: 7542533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the tachykinin receptors involved in spinal and supraspinal cardiovascular regulation.
    Couture R; Picard P; Poulat P; Prat A
    Can J Physiol Pharmacol; 1995 Jul; 73(7):892-902. PubMed ID: 8846427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
    Deschamps K; Couture R
    Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat.
    Tschöpe C; Picard P; Culman J; Prat A; Itoi K; Regoli D; Unger T; Couture R
    Br J Pharmacol; 1992 Nov; 107(3):750-5. PubMed ID: 1335337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular and behavioural effects induced by naloxone-precipitated morphine withdrawal in rat: characterization with tachykinin antagonists.
    Michaud N; Couture R
    Neuropeptides; 2003 Dec; 37(6):345-54. PubMed ID: 14698677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory action of (+/-)CP-96,345 on the cardiovascular responses to intrathecal substance P and neuropeptide K in the conscious freely moving rat.
    Pham TM; Couture R
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan; 347(1):34-41. PubMed ID: 7680439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of cardiac activity by tachykinins in the rat substantia nigra.
    Lessard A; Couture R
    Br J Pharmacol; 2001 Dec; 134(8):1749-59. PubMed ID: 11739252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interaction between losartan and central tachykinin NK3 receptors in the conscious rat.
    Picard P; Chrétien L; Couture R
    Br J Pharmacol; 1995 Apr; 114(8):1563-70. PubMed ID: 7541280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-FOS expression in the rat brain in response to substance P and neurokinin B.
    Spitznagel H; Baulmann J; Blume A; Unger T; Culman J
    Brain Res; 2001 Oct; 916(1-2):11-21. PubMed ID: 11597586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
    Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma extravasation induced by neurokinins in conscious rats: receptor characterization with agonists and antagonists.
    Nicolau M; Sirois MG; Bui M; Plante GE; Sirois P; Regoli D
    Can J Physiol Pharmacol; 1993; 71(3-4):217-21. PubMed ID: 7691388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are biological actions of neurokinin A in the adult brain mediated by a cross-talk between the NK1 and NK2 receptors?
    Tauer U; Zhao Y; Hunt SP; Culman J
    Neuropharmacology; 2012 Nov; 63(6):958-65. PubMed ID: 22771977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of a 'septide-sensitive' inflammatory response in rat skin.
    Ahluwalia A; Giuliani S; Maggi CA
    Br J Pharmacol; 1995 Oct; 116(4):2170-4. PubMed ID: 8564245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular and sympathoadrenal responses to intrathecal injection of neuropeptide K in the conscious rat.
    Pham TM; de Champlain J; Couture R
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan; 347(1):42-9. PubMed ID: 8446182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.